190 related articles for article (PubMed ID: 29080886)
1. Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.
Sudo K; Kato K; Kuwabara H; Sasaki Y; Takahashi N; Shoji H; Iwasa S; Honma Y; Okita NT; Takashima A; Hamaguchi T; Yamada Y; Ito Y; Itami J; Fukuda T; Tobinai K; Boku N
Oncology; 2018; 94(1):47-54. PubMed ID: 29080886
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
3. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
4. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy.
Liw PX; Wen YW; Tsai CY; Chang HK; Tseng CK; Hung TM; Chao YK
J Thorac Cardiovasc Surg; 2018 May; 155(5):2233-2242.e2. PubMed ID: 29397973
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
10. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K
Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523
[TBL] [Abstract][Full Text] [Related]
11. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
12. Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
Münch S; Pigorsch SU; Devečka M; Dapper H; Weichert W; Friess H; Braren R; Combs SE; Habermehl D
Radiat Oncol; 2018 Aug; 13(1):139. PubMed ID: 30068371
[TBL] [Abstract][Full Text] [Related]
13. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
14. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer.
Kawaguchi G; Sasamoto R; Abe E; Ohta A; Sato H; Tanaka K; Maruyama K; Kaizu M; Ayukawa F; Yamana N; Liu J; Takeuchi M; Kobayashi M; Aoyama H
Radiat Oncol; 2015 Jan; 10():31. PubMed ID: 25636830
[TBL] [Abstract][Full Text] [Related]
17. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.
Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S
Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223
[TBL] [Abstract][Full Text] [Related]
18. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
Crosby T; Hurt CN; Falk S; Gollins S; Staffurth J; Ray R; Bridgewater JA; Geh JI; Cunningham D; Blazeby J; Roy R; Maughan T; Griffiths G; Mukherjee S
Br J Cancer; 2017 Mar; 116(6):709-716. PubMed ID: 28196063
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.
Ego M; Abe S; Nakatani Y; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Kato K; Honma Y; Itami J; Daiko H; Saito Y; Boku N
Surg Endosc; 2021 Apr; 35(4):1766-1776. PubMed ID: 32356109
[TBL] [Abstract][Full Text] [Related]
20. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
